• We conducted thorough secondary research on the acquired product, disease area, competition, healthcare trends and potential future events. Using this data, we built a robust forecasting model.
• Our research included a review of medical literature, clinical trials, peer reviewed articles, syndicated reports, annual reports of competitors and coverage of the major medical conferences in the disease area of interest.

• Our detailed report included:
  • Information on therapy area, disease pathophysiology and current treatment algorithms
  • Competitive landscape for inline and pipeline products
  • Detailed attribute analysis of the key competitor products
  • Market value of inline products and market potential of the pipeline competitor products
  • Detailed forecast for the acquired product of interest
  • Our recommendation on investing in the product and developing it further vs. divesting it

Based on our recommendations, the client decided to do a further deep dive on the long-term revenue potential of the asset and retained us for that engagement as well.